DIN 02286300 — MITOXANTRONE INJECTION 2 MG
MITOXANTRONE INJECTION is a solution of Mitoxantrone marketed by FRESENIUS KABI CANADA LTD. The full Mitoxantrone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02286300
- Brand name
- MITOXANTRONE INJECTION
- Active ingredient
- Mitoxantrone
- Strength
- 2 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- FRESENIUS KABI CANADA LTD
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent (anthracenedione, topoisomerase II inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.